Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Get Free Report) saw a large decline in short interest in January. Hedge Funds Weigh In On Amplify Weight Loss Drug & Treatment ETFA hedge fund recently raised its stake in Amplify Weight Loss Drug & Treatment ETF stock. Get Amplify Weight Loss Drug & Treatment ETF alerts:Amplify Weight Loss Drug & Treatment ETF Stock PerformanceTHNR traded down $0.57 on Wednesday, hitting $26.12. Amplify Weight Loss Drug & Treatment ETF Dividend AnnouncementAbout Amplify Weight Loss Drug & Treatment ETFThe company also recently disclosed an annual dividend, which was paid on Wednesday, December 31st. (Get Free Report)The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index.